Cardiology

DAPT cessation patterns vary with diabetes status after PCI

(HealthDay)—For patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with a drug-eluting stent (DES), DAPT cessation is significantly lower in patients with diabetes mellitus (DM), ...

Oncology & Cancer

Wearable radiation safety devices offer some protection

(HealthDay)—Leaded glasses can offer some radiation protection of the ocular lenses, while a radioabsorbent surgical cap offers minimal protection of the brain, according to a study published in the March 13 issue of JACC: ...

Cardiology

Furosemide plus matched hydration cuts contrast-induced AKI

(HealthDay)—For high-risk patients undergoing percutaneous coronary intervention or transcatheter aortic valve replacement, furosemide with matched hydration via the RenalGuard system may reduce the incidence of contrast-induced ...

Cardiology

Ipsilateral ulnar compression cuts radial artery occlusion

(HealthDay)—Radial artery occlusion (RAO) after transradial access (TRA) can be cut significantly with prophylactic ipsilateral ulnar compression, according to a study published in the Oct. 10 issue of JACC: Cardiovascular ...

Cardiology

Risks, benefits of cangrelor consistent in angina, ACS

(HealthDay)—For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.

Cardiology

Thrombocytopenia up with use of phosphate-buffered tirofiban

(HealthDay)—For patients with acute coronary syndrome, phosphate-buffered tirofiban, but not citrate-buffered tirofiban, is associated with an increased risk of thrombocytopenia, according to a study published in the Aug. ...

Cardiology

DAPT use variable in patients with A-fib at risk of stroke

(HealthDay)—For patients with atrial fibrillation at moderate to high risk of stroke, dual antiplatelet therapy (DAPT) use is variable among those undergoing percutaneous coronary intervention (PCI), according to a study ...

Cardiology

Coenzyme Q10 doesn't prevent periprocedural myocardial injury

(HealthDay)—Pre-treatment with coenzyme Q10 (CoQ10) before elective percutaneous coronary intervention (PCI) does not reduce periprocedural myocardial injury (PMI), but does significantly decrease high-sensitivity C-reactive ...

Cardiology

Safety of TAVR examined in all-female cohort

(HealthDay)—In an all-female transcatheter aortic valve replacement (TAVR) registry, 14.0 percent of women experienced a 30-day Valve Academic Research Consortium (VARC-2) composite safety end point, according to a study ...

Cardiology

Emergency PCI linked to better outcomes

(HealthDay)—Almost one-third of out-of-hospital cardiac arrest (OHCA) patients without ST-segment elevation (STE) require percutaneous coronary intervention (PCI), which is tied to a nearly twofold increase in the rate ...

page 6 from 16